Dawn Kalmar

Dawn Kalmar is the Chief Communications Officer and Vice President, Head of Corporate Affairs at Stoke Therapeutics since April 2019. Prior to this, Dawn held various senior positions in corporate communications at Vertex Pharmaceuticals and Genentech. With a background in journalism and Spanish, Dawn has a wealth of experience in leading communications activities for FDA approvals and launches of breakthrough medicines, overseeing employee communications during times of growth and transition, and managing public relations for top medicines in oncology and eye disease. Dawn also has experience in leading communications activities for biotech and medical device clients at Ketchum.